Perdana Karya Perkasa Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Perdana Karya Perkasa Tbk trades at Rp3,800 (market cap 4.37T, 2.82M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 2.7× Perdana Karya Perkasa Tbk's market cap, and Perdana Karya Perkasa Tbk is more actively traded (2.82M versus 429.7K). Which is the better fit depends on your goals.
| PKPK | TSPC | |
|---|---|---|
Market Cap | 4.37T | 11.68T |
Volume | 2.82M | 429.7K |
Lot | 28.2K | 4.3K |
Turnover | 10.5B | 1.11B |
Average Price | 3,725.18 | 2,591.65 |
Value | 10.5B | 1.11B |
Indicative Equilibrium Price | 3,800 | 2,580 |
Indicative Equilibrium Volume | 1.31K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Perdana Karya Perkasa (the company) was established under its original name of PT Perdana Karya Kaltim on Dec 7, 1983 then changed to PT Perdana Karya Perkasa based on Notaries Deed dated Jun 30, 2006 and the deed of establishment was approved by the the Ministry of Justice dated Aug 9, 2006. The Company articles of association has been amended several times, most recently by notarial deed No. 46 of Marina Soewana, S.H., dated Sep 28, 2006, concerning among others, the change in the Company name and public offering
Read more on PKPK →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →